Stay updated with breaking news from Peter Keeling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canaccord Genuity Group reissued their buy rating on shares of Diaceutics (LON:DXRX – Free Report) in a research report report published on Tuesday morning, MarketBeat reports. They currently have a GBX 150 ($1.91) price objective on the stock. Diaceutics Price Performance DXRX stock opened at GBX 127.50 ($1.62) on Tuesday. The firm has a 50 […]
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Adnams PLC - Southwold, Suffolk-based brewer - Following...
Plans to relocate part of a flood-hit Pembrokeshire seaside village’s shingle sea defences to protect local businesses and the main A487 road have…
The founder and chief executive of Belfast-based medical technology firm Diaceutics is stepping down after nearly two decades at the helm.